Biote Corp. Class A Common Stock (BTMD) is a publicly traded Healthcare sector company. As of October 21, 2026, BTMD trades at $1.03 with a market cap of $30.69M and a P/E ratio of 1.34. BTMD moved -2.80% today. Year to date, BTMD is -58.30%; over the trailing twelve months it is -66.45%. Its 52-week range spans $1.00 to $4.75. Analyst consensus is strong buy with an average price target of $2.00. Rallies surfaces BTMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest BTMD news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $1.03 |
| Market Cap | $30.69M |
| P/E Ratio | 1.34 |
| EPS | $0.86 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.75 |
| 52-Week Low | $1.00 |
| Volume | 129.17K |
| Avg Volume | 0 |
| Revenue (TTM) | $192.22M |
| Net Income | $31.60M |
| Gross Margin | 0.00% |
4 analysts cover BTMD: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $2.00.